Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
Cell Res
.
2015 Mar;25(3):399-400.
doi: 10.1038/cr.2015.28.
Authors
Dalil Hannani
,
Marie Vétizou
,
David Enot
,
Sylvie Rusakiewicz
,
Nathalie Chaput
,
David Klatzmann
,
Melanie Desbois
,
Nicolas Jacquelot
,
Nadège Vimond
,
Salem Chouaib
,
Christine Mateus
,
James P Allison
,
Antoni Ribas
,
Jedd D Wolchok
,
Jianda Yuan
,
Philip Wong
,
Michael Postow
,
Andrzej Mackiewicz
,
Jacek Mackiewicz
,
Dirk Schadendorff
,
Dirk Jaeger
,
Alan J Korman
,
Keith Bahjat
,
Michele Maio
,
Luana Calabro
,
Michele Wl Teng
,
Mark J Smyth
,
Alexander Eggermont
,
Caroline Robert
,
Guido Kroemer
,
Laurence Zitvogel
PMID:
25732764
PMCID:
PMC4349252
DOI:
10.1038/cr.2015.28
No abstract available
Publication types
Published Erratum
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States